Change in HbA1c (baseline to post-trial) accounting for baseline characteristics
| Change in clinical characteristics | Control | Intervention | ||
|---|---|---|---|---|
| N | Mean (SD) | N | Mean (SD) | |
| Change in HbA1c (%) | ||||
| Baseline HbA1c ≤6.6% | 4 | +0.25 (0.30) | 8 | −0.14 (0.19) |
| Baseline HbA1c >6.6% | 8 | +0.04 (0.23) | 3 | −0.30 (0.20) |
| Change in HbA1c (%) | ||||
| Baseline BMI ≤27 kg/m2 | 4 | +0.25 (0.38) | 7 | −0.14 (0.21) |
| Baseline BMI >27 kg/m2* | 8 | +0.04 (0.17) | 4 | −0.25 (0.19) |
| Change in HbA1c (%) | ||||
| Baseline weight <68 kg | 6 | +0.03 (0.29) | 7 | −0.14 (0.21) |
| Baseline weight ≥68 kg | 6 | +0.03 (0.20) | 4 | −0.25 (0.19) |
*p<0.05 for change in HbA1c between intervention and control group.
BMI, body mass index; HbA1c, glycated hemoglobin.